Health & Safety Industry Today
Europe Clinical Trials Market size to Reach USD 34.52 Billion by 2031, Driven by Hybrid Study Models
Europe Clinical Trials Market Overview
According to Mordor Intelligence, the Europe clinical trials market size is estimated at USD 25.13 billion in 2026, growing from USD 23.59 billion in 2025, and is projected to reach USD 34.52 billion by 2031, registering a CAGR of 6.55% during the forecast period. This market growth reflects the region’s strong position in global drug development and clinical research activities.
The industry benefits from supportive regulatory frameworks, particularly the Clinical Trials Regulation, which simplifies study approvals and enhances transparency. The increasing adoption of decentralized and hybrid clinical trial models is also improving patient participation and retention, strengthening the market forecast. With growing demand for innovative therapies, especially in oncology and neurology, the region continues to attract both regional and global sponsors, contributing to rising Europe clinical trials market share.
Key Trends Shaping the Europe Clinical Trials Market
Rising Adoption of Hybrid and Decentralized Trials
One of the most notable Europe clinical trials market trends is the growing use of hybrid and decentralized clinical trials. These models combine traditional site-based research with remote monitoring and digital tools, making participation easier for patients across diverse locations. This shift is helping reduce delays and operational costs while improving data collection efficiency, contributing positively to the market growth.
Strong Focus on Oncology and Neurology Research
Oncology remains a major driver of the Europe clinical trials industry, with a continuous flow of late-stage studies supported by strong investment. At the same time, neurology research is gaining momentum due to the aging population and increasing prevalence of neurological conditions. These therapeutic areas are expected to maintain a significant share in the market, reinforcing long-term market forecast.
Regulatory Improvements Enhancing Study Approvals
Regulatory changes across Europe are simplifying the clinical trial approval process. The implementation of streamlined procedures is enabling faster study start-ups and improved coordination across multiple countries. These improvements are strengthening sponsor confidence and increasing trial activity, supporting sustained Europe clinical trials market growth.
Hybrid Outsourcing Models Gaining Popularity
Sponsors are increasingly adopting hybrid outsourcing strategies that combine large contract research organizations with specialized service providers. This approach allows for better cost management, flexibility, and faster execution of trials. Such models are becoming a defining feature of the Europe clinical trials market trends, helping organizations remain competitive in a dynamic environment.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/europe-clinical-trials-market?utm_source=industrytoday.co.uk
Europe Clinical Trials Market Segmentation Analysis
By Phase
- Phase I
- Phase II
- Phase III
- Phase IV
By Study Design
- Interventional or treatment studies
- Observational studies
- Expanded access studies
By Service Type
- Protocol design and feasibility
- Site identification and start-up
- Regulatory submission and approval
- Clinical trial monitoring
- Data management and biostatistics
- Medical writing
- Other service types
By Therapeutic Area
- Oncology
- Cardiovascular
- Neurology
- Infectious diseases
- Metabolic disorders
- Immunology and autoimmune
- Other therapeutic areas
By Sponsor Type
- Pharmaceutical and biopharmaceutical companies
- Medical device companies
- Academic and research institutes
- Government and non-profit organizations
By Geography
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
Explore Our Full Library of Healthcare Research Report:
https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday.co.uk
Europe Clinical Trials Market Key Players and Competitive Landscape
The Europe clinical trials market is characterized by the presence of established global players as well as specialized service providers. These companies play a critical role in supporting sponsors through various stages of clinical development and contribute significantly to the industry.
Leading Companies in the Market
- IQVIA
- Parexel International Corporation
- ICON plc
- Thermo Fisher Scientific Inc.
- Laboratory Corporation of America Holdings
Explore more insights on Europe clinical trials competitive landscape: https://www.mordorintelligence.com/industry-reports/europe-clinical-trials-market/companies?utm_source=industrytoday.co.uk
Conclusion
The Europe clinical trials market continues to demonstrate resilience and steady expansion, supported by strong research activity and evolving study designs. The combination of regulatory support, experienced research networks, and increasing adoption of hybrid trial models is helping the region maintain a stable market share in the global landscape.
Looking ahead, the market forecast remains positive, with ongoing demand for innovative therapies and efficient trial execution. Growth in oncology and neurology research, along with improvements in patient accessibility, is expected to sustain long-term Europe clinical trials market growth.
In conclusion, the industry is well-positioned to adapt to changing research needs while maintaining its importance in global clinical development. Continued focus on efficiency, collaboration, and patient-centric approaches will further strengthen the Europe clinical trials market size and ensure its role in advancing healthcare solutions across the region.
Get detailed insights on the Europe clinical trials market:
Industry Related Reports
Lipid Nanoparticle CDMO Market:
Advanced Drug Delivery CDMO Market size:
Inhalation CDMO Market share:
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
https://www.mordorintelligence.com/
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
